Aaron brings over 15 years of early-stage medtech investing to MCF.
Aaron joined in 2020 as a founding Partner of the Medtech Convergence Fund (MCF). He is a Managing Director of Norwich Ventures, a predecessor to MCF.
Aaron is the Managing Director of Norwich Ventures, an early-stage medtech VC he co-founded in 2004. His investments at Norwich include Affera, Arterys, IonPath, Lexington Medical, Podimetrics, Vaxess, Intelligent Bio-systems (acquired by Qiagen) and Rhythmia Medical (acquired by Boston Scientific). Previously, Aaron worked for DEKA, the engineering think tank of Dean Kamen, and two start-up companies that were acquired. Aaron began his career as a consultant at McKinsey & Company.
Aaron serves on the Board of MassMEDIC and regularly guest lectures on medical technology, innovation, and finance at Harvard and Stanford. He is the author of How the Wise Decide, a book on decision-making that has been translated into 11 foreign languages. Aaron enjoys finding new adventures with his family and is passionate about classic cars.
AB, Chemistry and Economics, Dartmouth College; MBA, Harvard Business School